Clinical trials
Phase 4 Burns trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 9 |
| Recruiting | 6 |
| Unknown status | 5 |
| Withdrawn | 5 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Kansas Medical Center | 3 |
| University of Tennessee | 3 |
| Association of Dutch Burn Centres | 2 |
| The Metis Foundation | 2 |
| University of Zurich | 2 |
| Alnas Hospital | 1 |
| CellTherX | 1 |
| Cellution Biologics | 1 |
| Centre Hospitalier Saint Joseph Saint Luc de Lyon | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burns | 48 |
| Wounds and Injuries | 4 |
| Agnosia | 2 |
| Neoplasm Metastasis | 2 |
| Pain | 2 |
| Stress Disorders, Post-Traumatic | 2 |
| Wound Infection | 2 |
| Acute Pain | 1 |
| Adrenal Insufficiency | 1 |
| Cicatrix | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.